In a groundbreaking global study spanning a decade, researchers have discovered that a daily pill called osimertinib can reduce the risk of dying from lung cancer by 51%. The results, presented at the American Society of Clinical Oncology's annual meeting, have been hailed as "thrilling" and "unprecedented."
from Sputnik News - World News, Breaking News & Top Storie https://ift.tt/tASGT0K
via IFTTT
No comments:
Post a Comment